and summarised the proof. Outcomes: The selected PICO query was: what is the efficacy and safety of thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in patients hospitalized for nonsurgical reasons The original search located 498 articles, reviewed by title/abstract, leaving 30 for overview by text. Excellent tools (PRISMA and AMSTAR2) had been applied to a total of 18 papers, with 7 systematic evaluations and meta-analyses lastly chosen. The reviewers critically appraised this evidence, distilled it into a Summary of Findings Table, and wrote brief summaries.PO173|Venous Thromboembolism Prophylaxis through Hospitalization: Evidence-based Recommendation (by an Internal Medicine Team) F.J. V quez; M.F. Grande Ratti; M.G. Vallone; P.G. Paula Guadalupe Gutierrez; M.B. Bonella; D. Andresik; A. Freixas; M.L. Peroni; D.S. Thomas; C.M.U. Ungaro; M. Burgos; D.H. Giunta; H.M. Recchioni; M.M. Serra; B. Martinez; H. Michelangelo; J.A. Poll ; B.R. Boietti; V.A. Peuchot Hospital Italiano de Buenos Aires, Buenos Aires, Argentina Background: Hospitalization is definitely an critical opportunity for applying prevention efforts. International clinical practice suggestions are for person healthcare practitioners, who must use them in their operate in conjunction with their very own judgment and discussion. That ‘s why in 2019, a committee with physicians from Internal Medicine at Hospital Italiano de Buenos Aires, initiated an effort to develop evidence-based suggestions related to Venous Thromboembolism prophylaxis through clinical hospitalization, that meet the highest requirements of development, rigor, and trustworthiness. FIGURE two Summary of findings table (Element II) FIGURE 1 Summary of findings table (Part I)ABSTRACT905 of|Conclusions: The consolidation of a functioning group, the construction of an academic space -in order to understand, disseminate the GRADE methodology and important reading of evidence-, the coaching and participation of your potential customers from the final recommendations, could increase health care outcomes. It truly is pending to measure postimplementation adherence.PO185|Analysis of Danger Variables for Hemorrhagic Complications of Anticoagulant Therapy N. Vorobyeva1,two; A. Shchapkov2; E. MelnichukNational Medical Analysis Center for Hematology (Northern Branch) Northern State Healthcare University Ministry of Wellness of Russia,Ministry of Health of Russia, Arckhangelsk, Russian Federation;Arckhangelsk, Russian Federation PO174|Pharmacological Venous Thromboembolism Prophylaxis in an Internal Medicine Ward: Cross-sectional Observational Study G. Durao-Carvalho; A. Canoso; J. Louro; R. Amorim Division of Internal Medicine | Centro Hospitalar do Oeste Unidade de Caldas da Rainha, Caldas da Rainha, Portugal Background: Half in the venous thromboembolism (VTE) circumstances occur in inpatients. Aims: Use of pharmacological VTE prophylaxis in healthcare inpatients. Approaches: Observational, cross-sectional study with inpatients ( 24h due to the fact admission) in the Internal Medicine ward, on a random weekday. Improve VTE and Enhance bleeding danger (BR) scores had been CA I Inhibitor Gene ID calculated, with stratification into 3 threat cohorts. Results: 38 patients, 44,7 males, IL-17 Inhibitor Compound median age of 80 years old. 60,five had a low-molecular-weight heparin (LMWH) prescribed (15 sufferers – prophylactic dose; eight – therapeutical dose). No other anticoagulation drug was discovered. VTE low-risk cohort: 6 individuals were anticoagulated. two of them had clinical indication related for the hospitalization diagnosis (pulmo